Stock analysis posts tagged "consumer staples" from Openbook.
Reckitt cut full-year revenue growth guidance to 3.5%-4.5% after Lysol capacity limits hit North America. Shares closed 4.85% lower at 5,218p.
PepsiCo cut full-year core EPS guidance to 2.5-3.5% growth and the shares still rose 3.73% to USD 128.34. Why the market chose to buy a downgrade.
Grain costs up 17.7% and packaging rising: General Mills held organic sales flat but lost 11% of adjusted operating profit to the input-cost squeeze.
A Philip Morris stock analysis of the PM smoke-free shift. We look at Q2 2026 revenue, IQOS and ZYN volumes, margins, leverage and the newly raised dividend.
A Diageo stock analysis built on the FY2026 accounts: net sales, the North America slowdown, the rebased dividend, and reading pence quotes against dollar earnings.
A unanimous federal jury cleared Reckitt's Mead Johnson unit in the first NEC bellwether. The shares rose 4.3% - here is what one verdict prices.
A Reckitt Benckiser stock analysis of the H1 2026 numbers: revenue, margins, dividend, the Essential Home disposal and the unresolved Mead Johnson exit.
A Coca-Cola stock analysis of the concentrate model, second quarter 2026 results, unit case volume, the dividend record and the risks now in play.
Costco stock analysis: how membership fees, an 11% gross margin and steady warehouse openings shape what COST actually reports each quarter.
A Procter and Gamble (PG) stock analysis grounded in the fiscal 2026 results: organic sales, margins, the dividend record and the fiscal 2027 cost headwinds worth watching.
A Unilever stock analysis of the H1 2026 results: volume-led growth, margins, cash flow and the dividend. We look at what drives the numbers and what to watch next.
A British American Tobacco stock analysis: how BATS earns from cigarettes and smokeless nicotine, and what its dividend, debt and risks show.